158 related articles for article (PubMed ID: 23229417)
1. Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent.
Hegde A; Smith AL; Aguilar VC; Davila GW
Int Urogynecol J; 2013 Jul; 24(7):1151-9. PubMed ID: 23229417
[TBL] [Abstract][Full Text] [Related]
2. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence.
Bano F; Barrington JW; Dyer R
Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(2):147-50; discussion 150. PubMed ID: 15378234
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional ultrasonography: an objective outcome tool to assess collagen distribution in women with stress urinary incontinence.
Defreitas GA; Wilson TS; Zimmern PE; Forte TB
Urology; 2003 Aug; 62(2):232-6. PubMed ID: 12893325
[TBL] [Abstract][Full Text] [Related]
4. Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency.
Radley SC; Chapple CR; Mitsogiannis IC; Glass KS
Eur Urol; 2001 Apr; 39(4):383-9. PubMed ID: 11306875
[TBL] [Abstract][Full Text] [Related]
5. The Location and Distribution of Transurethral Bulking Agent: 3-Dimensional Ultrasound Study.
Yune JJ; Quiroz L; Nihira MA; Siddighi S; O'Leary DE; Santiago A; Shobeiri SA
Female Pelvic Med Reconstr Surg; 2016; 22(2):98-102. PubMed ID: 26516814
[TBL] [Abstract][Full Text] [Related]
6. Treatment of postoperative male urinary incontinence using transurethral macroplastique injections.
Kylmälä T; Tainio H; Raitanen M; Tammela TL
J Endourol; 2003 Mar; 17(2):113-5. PubMed ID: 12689406
[TBL] [Abstract][Full Text] [Related]
7. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study.
Ghoniem G; Corcos J; Comiter C; Bernhard P; Westney OL; Herschorn S
J Urol; 2009 Jan; 181(1):204-10. PubMed ID: 19013613
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Macroplastique injections for stress urinary incontinence after suburethral sling removal.
Rodríguez D; Carroll T; Alhalabi F; Carmel M; Zimmern PE
Neurourol Urodyn; 2020 Mar; 39(3):994-1001. PubMed ID: 32068306
[TBL] [Abstract][Full Text] [Related]
9. Durability of Macroplastique volume and configuration in women with stress urinary incontinence secondary to intrinsic sphincter deficiency: A retrospective review.
Carroll TF; Christie A; Foreman M; Kuprasertkul A; Khatri G; Zimmern PE
Low Urin Tract Symptoms; 2021 Jul; 13(3):335-340. PubMed ID: 33354906
[TBL] [Abstract][Full Text] [Related]
10. Periurethral Mass Mimicking Neoplasm After Injection of Macroplastique for Postprostatectomy Stress Incontinence: A Pitfall on 18F-FDG PET/CT.
Richard C; Dejust S; Moubtakir A; Bruna-Muraille C; Morland D
Clin Nucl Med; 2018 May; 43(5):381-382. PubMed ID: 29517541
[TBL] [Abstract][Full Text] [Related]
11. Role of three-dimensional ultrasound in assessment of women undergoing urethral bulking agent therapy.
Poon CI; Zimmern PE
Curr Opin Obstet Gynecol; 2004 Oct; 16(5):411-7. PubMed ID: 15353951
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and treatment of Macroplastique® urethral exposures: a retrospective case series.
Ramirez-Caban L; Malekzadeh M; Ossin DA; Hurtado EA
Int Urogynecol J; 2022 Mar; 33(3):681-687. PubMed ID: 34213601
[TBL] [Abstract][Full Text] [Related]
13. Urethral injection therapy for urinary incontinence in women.
Kirchin V; Page T; Keegan PE; Atiemo K; Cody JD; McClinton S
Cochrane Database Syst Rev; 2012 Feb; (2):CD003881. PubMed ID: 22336797
[TBL] [Abstract][Full Text] [Related]
14. [Urethral Macroplastique injection as a treatment for female stress incontinence].
Sander P; Mouritsen AL; Lose G
Ugeskr Laeger; 2004 Aug; 166(36):3100-2. PubMed ID: 15387310
[No Abstract] [Full Text] [Related]
15. Can Urethral Bulking Agents Salvage Failed Slings?
Dray EV; Hall M; Covalschi D; Cameron AP
Urology; 2019 Feb; 124():78-82. PubMed ID: 30412703
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of polydimethylsiloxane injection (Macroplastique
Serati M; Soligo M; Braga A; Cantaluppi S; Coluccia AC; Di Dedda MC; Salvatore S; Cetin I; Ghezzi F;
BJU Int; 2019 Feb; 123(2):353-359. PubMed ID: 30253026
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence.
Ghoniem GM; Miller CJ
Int Urogynecol J; 2013 Jan; 24(1):27-36. PubMed ID: 22699885
[TBL] [Abstract][Full Text] [Related]
18. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review.
Siddiqui ZA; Abboudi H; Crawford R; Shah S
Int Urogynecol J; 2017 Sep; 28(9):1275-1284. PubMed ID: 28220200
[TBL] [Abstract][Full Text] [Related]
19. The treatment of sphincter incontinence with periurethral silicone implants (macroplastique).
Peeker R; Edlund C; Wennberg AL; Fall M
Scand J Urol Nephrol; 2002; 36(3):194-8. PubMed ID: 12201934
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional ultrasonography to assess long-term durability of periurethral collagen in women with stress urinary incontinence due to intrinsic sphincter deficiency.
Poon CI; Zimmern PE; Wilson TS; Defreitas GA; Foreman MR
Urology; 2005 Jan; 65(1):60-4. PubMed ID: 15667864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
